Cargando…

AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non‐small cell lung cancer: Results of a retrospective study

BACKGROUND: A‐kinase–interacting protein 1 (AKIP1) has been reported as an oncogenetic factor in multiple cancers; however, no study has reported its role in non‐small cell lung cancer (NSCLC) yet. This study aimed to evaluate the expression of AKIP1, and its correlation with tumor characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yingchao, Tian, Jia, Qin, Dongrui, Liu, Jiaqi, Xie, Yaozeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171317/ https://www.ncbi.nlm.nih.gov/pubmed/31782840 http://dx.doi.org/10.1002/jcla.23128

Ejemplares similares

Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer
por: Jiang, Weifang, et al.
Publicado: (2018)

AKIP1 Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes
por: Yu, Hongjuan, et al.
Publicado: (2013)

MiR-320 regulates cardiomyocyte apoptosis induced by ischemia–reperfusion injury by targeting AKIP1
por: Tian, Zhi-Qiang, et al.
Publicado: (2018)

Cell-Penetrating Peptides Predicted From CASC3, AKIP1, and AHRR Proteins
por: Porosk, Ly, et al.
Publicado: (2021)

Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
por: Zhu, Lin, et al.
Publicado: (2022)

AKIP1, a Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt Pathway
por: Yu, Hongjuan, et al.
Publicado: (2013)

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling
por: Nijholt, Kirsten T., et al.
Publicado: (2023)

A‐kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients
por: Fang, Tao, et al.
Publicado: (2020)

Elevated AKIP1 expression is associated with tumor invasion, shorter survival time and decreased chemosensitivity in endometrial carcinoma
por: Li, Aili, et al.
Publicado: (2022)

Silencing of AKIP1 Suppresses the Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Glioma Cells by Upregulating DLG2
por: Chen, Zhaohui, et al.
Publicado: (2022)

Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients
por: Wan, Xiaoyan, et al.
Publicado: (2020)

PKA and AKIP1 interact to mediate cAMP-driven COX-2 expression: A potentially pivotal interaction in preterm and term labour
por: Yulia, Angela, et al.
Publicado: (2021)

Goal-directed perfusion to reduce acute kidney injury after paediatric cardiac surgery (GDP-AKIp): study protocol for a prospective randomised controlled trial
por: Zhang, Yan, et al.
Publicado: (2020)

Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non–Small Cell Lung Cancer
por: Li, Nandi, et al.
Publicado: (2017)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
por: Li, Long-Qing, et al.
Publicado: (2020)

Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides
por: Tombetti, Enrico, et al.
Publicado: (2021)

Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer
por: Jia, Sinong, et al.
Publicado: (2021)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study
por: Xu, Linrui, et al.
Publicado: (2023)

The analysis of prognosis factor in patients with non-small cell lung cancer receiving pneumonectomy
por: Wang, Guige, et al.
Publicado: (2020)

Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study
por: Li, Yanli, et al.
Publicado: (2023)

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
por: Liu, Xingyuan, et al.
Publicado: (2019)

Small extrachromosomal circular DNAs as biomarkers for multi‐cancer diagnosis and monitoring
por: Luo, Xuanmei, et al.
Publicado: (2023)

Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Gong, Ke, et al.
Publicado: (2021)

Transfer RNA-derived small RNAs: potential applications as novel biomarkers for disease diagnosis and prognosis
por: Jia, Yang, et al.
Publicado: (2020)

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis
por: Ni, Mengwei, et al.
Publicado: (2018)

High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer
por: Liu, Shuang, et al.
Publicado: (2019)

Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non‐small cell lung cancer
por: Li, Lan, et al.
Publicado: (2019)

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2020)

Remark on “Establishment and Validation of the Risk Nomogram of Poor Prognosis in Patients with Severe Pulmonary Infection Complicated with Respiratory Failure” by Qiang et al [Letter]
por: Liang, Dongrui, et al.
Publicado: (2023)

The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Small intestinal microbiota composition and the prognosis of infants with ileostomy resulting from distinct primary diseases
por: Qian, Tian, et al.
Publicado: (2020)

The fruit morphometric variation and fruit type evolution of the stone oaks (Fagaceae, Lithocarpus)
por: Chen, Xi, et al.
Publicado: (2023)

Perioperative changes of inflammation-based biomarker for predicting the prognosis in colorectal cancer patients: a retrospective analysis
por: Ya, Xie, et al.
Publicado: (2019)

Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study
por: Yan, Yi, et al.
Publicado: (2022)

Retrospective Analysis of Clinicopathological Features and Prognosis of Gynecological Small-Cell Carcinoma
por: Pang, Li, et al.
Publicado: (2021)

Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
por: Tian, Yanjun, et al.
Publicado: (2019)

Utility of salivary biomarkers for diagnosis and monitoring the prognosis of nicotine addiction - A systematic review
por: Shreya, S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_662uehvbf5nutjjbpuuhv79gfj